Cocrystal Pharma, Inc. 通过一份提交给美国证券交易委员会（SEC）的文件宣布，其研究团队已成功发现一类新型广谱抗病毒抑制剂。该抑制剂展现出针对多种重要病毒的潜在活性，包括汉坦病毒、布尼亚病毒以及流感病毒。
这一发现标志着公司在抗病毒药物研发领域取得了重要进展。所发现的抑制剂旨在靶向病毒生命周期中的关键且保守的环节，从而可能对多种相关病毒株产生抑制作用，具备成为“泛病毒”疗法的潜力。
公司表示，相关发现是基于其专有的药物发现平台技术取得的。下一步，Cocrystal计划推进这些先导化合物的临床前开发工作，以进一步评估其安全性和有效性，为未来可能的临床研究奠定基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.